UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000062413
Receipt number R000071422
Scientific Title Acquisition of communication means using an eye-gaze input device in two children with severe physical disabilities ineligible for public subsidy of communication aids: A single-case experimental design
Date of disclosure of the study information 2026/08/15
Last modified on 2026/07/30 18:02:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on communication support using an eye-gaze input device for children with severe physical disabilities

Acronym

Gaze-Communication Support Study

Scientific Title

Acquisition of communication means using an eye-gaze input device in two children with severe physical disabilities ineligible for public subsidy of communication aids: A single-case experimental design

Scientific Title:Acronym

Gaze-Communication SCED Study

Region

Japan


Condition

Condition

Severe physical disability (regardless of underlying etiology)

Classification by specialty

Pediatrics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to verify, using a single-case experimental design, the effect of support for acquiring communication means using an eye-gaze input device, provided to two children with severe physical disabilities whose experience in using such devices and opportunities to learn them are limited because they are ineligible for the public subsidy system for communication aids for persons with severe disabilities (Assistive Device Subsidy System).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Goal Attainment Scaling (GAS) scores (5-point scale, -2 to +2) rating the degree of attainment of three target behaviors of eye-gaze-based communication (Task 1: conversational context; Task 2: situational context; Task 3: emotional context). GAS is measured at every session, and its trajectory across the baseline, intervention, and follow-up phases is evaluated by visual analysis and effect size (Tau-U).

Key secondary outcomes

Performance and satisfaction scores of the Canadian Occupational Performance Measure (COPM), and their change scores, administered to each participant's guardian at three time points: early baseline, immediately after the intervention phase, and late follow-up (3 months after the end of the intervention).


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Using an eye-gaze input device and communication software (fixed phrases arranged in a 12-16 cell layout), the intervention supports the child's expression of intentions during routine daily care sessions at an after-school day-service facility. Based on a multiple-baseline design across behaviors, the intervention is introduced in a staggered manner to three target behaviors (Task 1: yes/no responses to questions; Task 2: greetings/expressions of thanks; Task 3: expressing impressions/feedback), with intensive practice given to only the one behavior currently in its intervention phase while the others remain without practice until they enter their own intervention phase. Each session lasts about 20-30 minutes excluding device setup, and each behavior's intervention phase is capped at roughly 10 sessions. No intervention is provided during the baseline phase (at least 5 sessions) or the 3-month follow-up phase (5 sessions per month). The total study period is expected to be about 6 months.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 years-old <=

Age-upper limit

18 years-old >

Gender

Male and Female

Key inclusion criteria

All of the following must be met:
(1) The child is generally judged to be ineligible for subsidy under the public subsidy system for assistive devices (communication aids for persons with severe disabilities) by a certified assistive-technology adviser well versed in communication devices.
(2) Due to severe physical disability, the child has difficulty communicating through bodily movements such as speech or writing.
(3) The child is judged to retain a certain level of visual function and of arousal/attention necessary to operate an eye-gaze input device.
(4) The child continuously attends the after-school day-service facility serving as the study site, and participation throughout the study period is anticipated.
(5) Written consent for study participation is obtained from the proxy consenter (guardian).

Key exclusion criteria

Cases in which continued study participation is judged to place a physical or psychological burden on the child, such as unstable physical condition.

Target sample size

2


Research contact person

Name of lead principal investigator

1st name Shinya
Middle name
Last name Sakai

Organization

Ota College of Medical Technology

Division name

University Establishment Preparation Office

Zip code

373-0812

Address

1373 Higashinagaoka-cho, Ota-shi, Gunma, Japan

TEL

0276-25-2414

Email

s-sakai@ojs.ac.jp


Public contact

Name of contact person

1st name Shinya
Middle name
Last name Sakai

Organization

Ota College of Medical Technology

Division name

University Establishment Preparation Office

Zip code

373-0812

Address

1373 Higashinagaoka-cho, Ota-shi, Gunma, Japan

TEL

0276-25-2414

Homepage URL


Email

s-sakai@ojs.ac.jp


Sponsor or person

Institute

iCare Hokkaido, Specified Nonprofit Corporation

Institute

Department

Personal name



Funding Source

Organization

The Nippon Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor

Japan Healthcare University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ota College of Medical Technology Research Ethics Committee

Address

1373 Higashinagaoka-cho, Ota-shi, Gunma, Japan

Tel

0276-25-2414

Email

omt-post@ojs.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

放課後デイばおばぶ(北海道)


Other administrative information

Date of disclosure of the study information

2026 Year 08 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 07 Month 31 Day

Date of IRB


Anticipated trial start date

2026 Year 08 Month 24 Day

Last follow-up date

2027 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 07 Month 30 Day

Last modified on

2026 Year 07 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071422